It’s well known that medical devices get to market, on average, two years faster in the European Union than in the United States. The device lag, as it is known, is one of the main reasons why so many medical device manufacturers have adopted a “Europe first” strategy when marketing a new device. The approval process in the United States also is quite onerous. It’s a hurdle that UK-based Timesulin, which has developed a smart cap for insulin pens sold in 40 countries, has yet to clear. Tagging Options Domain:  All Sites Keywords:  medical Polymers read more

Excerpt from:
Smart cap for insulin pens tries to crack U.S. market via crowdfunding campaign